Worsening Renal Function Defined As an Absolute Increase in Serum Creatinine is a Biased Metric for the Study of Cardio-renal Interactions

Overview

Journal Cardiology

Specialty Cardiology & Vascular Diseases

Date 2010 Aug 7

PMID 20689277

Citations 35

Authors

Jeffrey M Testani

Brian D McCauley

Jennifer Chen

Michael Shumski

Richard P Shannon

Affiliations

Soon will be listed here.

Abstract

Objectives: Worsening renal function (WRF) during the treatment of decompensated heart failure, frequently defined as an absolute increase in serum creatinine >or=0.3 mg/dl, has been reported as a strong adverse prognostic factor in several studies. We hypothesized that this definition of WRF is biased by baseline renal function secondary to the exponential relationship between creatinine and renal function.

Methods: We reviewed consecutive admissions with a discharge diagnosis of heart failure. An increase in creatinine >or=0.3 mg/dl (WRF(CREAT)) was compared to a decrease in GFR >or=20% (WRF(GFR)).

Results: Overall, 993 admissions met eligibility. WRF(CREAT) occurred in 31.5% and WRF(GFR) in 32.7%. WRF(CREAT) and WRF(GFR) had opposing relationships with baseline renal function (OR = 1.9 vs. OR = 0.51, respectively, p < 0.001). Both definitions had similar unadjusted associations with death at 30 days [WRF(GFR) OR = 2.3 (95% CI 1.1-4.8), p = 0.026; WRF(CREAT) OR = 2.1 (95% CI 1.0-4.4), p = 0.047]. Controlling for baseline renal insufficiency, WRF(GFR) added incrementally in the prediction of mortality (p = 0.009); however, WRF(CREAT) did not (p = 0.11).

Conclusions: WRF, defined as an absolute change in serum creatinine, is heavily biased by baseline renal function. An alternative definition of WRF should be considered for future studies of cardio-renal interactions.

Citing Articles

Sodium-Glucose-Cotransporter-2 Inhibitor Therapy and Intermitted Fasting in Cardiorenal Syndrome: The Role of Glucose-Mediated Oxidative Stress.

Schroder K J Clin Med. 2025; 14(3).

PMID: 39941418 PMC: 11818847. DOI: 10.3390/jcm14030746.

Cardiorenal syndrome: evolving concepts and pediatric knowledge gaps.

Kula A, Bartlett D Pediatr Nephrol. 2024; 40(3):651-660.

PMID: 39331078 DOI: 10.1007/s00467-024-06517-z.

A Mild Increase in Serum Creatinine after Surgery Is Associated with Increased Mortality.

Xu L, Tang L, Zheng X, Yang L J Clin Med. 2024; 13(16).

PMID: 39201048 PMC: 11355709. DOI: 10.3390/jcm13164905.

Cardiovascular Consequences of Acute Kidney Injury: Treatment Options.

Voicehovska J, Trumpika D, Voicehovskis V, Bormane E, Busmane I, Grigane A Biomedicines. 2023; 11(9).

PMID: 37760806 PMC: 10526099. DOI: 10.3390/biomedicines11092364.

Telmisartan versus EnalapRil In heart failure with redUced ejection fraction patients with Moderately impaired kidney Functions; randomized controlled trial: "TRIUMF trial".

Samir A, Aboel-Naga S, Shehata A, Abdelhamid M Egypt Heart J. 2023; 75(1):68.

PMID: 37552407 PMC: 10409965. DOI: 10.1186/s43044-023-00398-7.

References

Cowie M, Komajda M, Murray-Thomas T, Underwood J, Ticho B . Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). Eur Heart J. 2006; 27(10):1216-22. DOI: 10.1093/eurheartj/ehi859. View

Campbell R, Sui X, Filippatos G, Love T, Wahle C, Sanders P . Association of chronic kidney disease with outcomes in chronic heart failure: a propensity-matched study. Nephrol Dial Transplant. 2008; 24(1):186-93. PMC: 2721423. DOI: 10.1093/ndt/gfn445. View

Mullens W, Abrahams Z, Francis G, Skouri H, Starling R, Young J . Sodium nitroprusside for advanced low-output heart failure. J Am Coll Cardiol. 2008; 52(3):200-7. DOI: 10.1016/j.jacc.2008.02.083. View

Tidman M, Sjostrom P, Jones I . A Comparison of GFR estimating formulae based upon s-cystatin C and s-creatinine and a combination of the two. Nephrol Dial Transplant. 2007; 23(1):154-60. DOI: 10.1093/ndt/gfm661. View

Testani J, Chen J, McCauley B, Kimmel S, Shannon R . Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation. 2010; 122(3):265-72. PMC: 3025294. DOI: 10.1161/CIRCULATIONAHA.109.933275. View

Klein L, Massie B, Leimberger J, OConnor C, Pina I, Adams Jr K . Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure.... Circ Heart Fail. 2009; 1(1):25-33. DOI: 10.1161/CIRCHEARTFAILURE.107.746933. View

Forman D, Butler J, Wang Y, Abraham W, OConnor C, Gottlieb S . Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004; 43(1):61-7. DOI: 10.1016/j.jacc.2003.07.031. View

Ochiai M, Barretto A, Oliveira Jr M, Munhoz R, Morgado P, Ramires J . Uric acid renal excretion and renal insufficiency in decompensated severe heart failure. Eur J Heart Fail. 2005; 7(4):468-74. DOI: 10.1016/j.ejheart.2004.09.018. View

Levey A, Coresh J, Greene T, Stevens L, Zhang Y, Hendriksen S . Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006; 145(4):247-54. DOI: 10.7326/0003-4819-145-4-200608150-00004. View

10.

Naruse H, Ishii J, Kawai T, Hattori K, Ishikawa M, Okumura M . Cystatin C in acute heart failure without advanced renal impairment. Am J Med. 2009; 122(6):566-73. DOI: 10.1016/j.amjmed.2008.10.042. View

11.

Butler J, Forman D, Abraham W, Gottlieb S, Loh E, Massie B . Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J. 2004; 147(2):331-8. DOI: 10.1016/j.ahj.2003.08.012. View

12.

Nohria A, Hasselblad V, Stebbins A, Pauly D, Fonarow G, Shah M . Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol. 2008; 51(13):1268-74. DOI: 10.1016/j.jacc.2007.08.072. View

13.

Mullens W, Abrahams Z, Francis G, Sokos G, Taylor D, Starling R . Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009; 53(7):589-596. PMC: 2856960. DOI: 10.1016/j.jacc.2008.05.068. View

14.

Formiga F, Chivite D, Manito N, Casas S, Riera A, Pujol R . Predictors of in-hospital mortality present at admission among patients hospitalised because of decompensated heart failure. Cardiology. 2006; 108(2):73-8. DOI: 10.1159/000095885. View

15.

Gottlieb S, Abraham W, Butler J, Forman D, Loh E, Massie B . The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail. 2002; 8(3):136-41. DOI: 10.1054/jcaf.2002.125289. View

16.

Delanaye P, Cohen E . Formula-based estimates of the GFR: equations variable and uncertain. Nephron Clin Pract. 2008; 110(1):c48-53. DOI: 10.1159/000151436. View

17.

Ma Y, Zuo L, Chen J, Luo Q, Yu X, Li Y . Improved GFR estimation by combined creatinine and cystatin C measurements. Kidney Int. 2007; 72(12):1535-42. DOI: 10.1038/sj.ki.5002566. View

18.

Damman K, Navis G, Voors A, Asselbergs F, Smilde T, Cleland J . Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail. 2007; 13(8):599-608. DOI: 10.1016/j.cardfail.2007.04.008. View

19.

Stevens L, Coresh J, Schmid C, Feldman H, Froissart M, Kusek J . Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis. 2008; 51(3):395-406. PMC: 2390827. DOI: 10.1053/j.ajkd.2007.11.018. View

20.

Heywood J, Fonarow G, Costanzo M, Mathur V, Wigneswaran J, Wynne J . High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail. 2007; 13(6):422-30. DOI: 10.1016/j.cardfail.2007.03.011. View